A marker for in vivo TXA2 synthesis
Related Products
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

11-dehydro Thromboxane B2

Item No. 19500

Technical Information
Formal Name
9α,15S-dihydroxy-11-oxothromba-5Z,13E-dien-1-oic acid
CAS Number
67910-12-7
Synonyms
  • 11-dehydro TXB2
  • 11-keto TXB2
Molecular Formula
C20H32O6
Formula Weight
Purity
≥98%
A 500 µg/ml solution in methyl acetate
DMF: 50 mg/ml (from TXB2)DMSO: 25 mg/ml (from TXB2)Ethanol: 100 mg/ml (from TXB2)PBS pH 7.2: 100 µg/ml (from TXB2)
SMILES
CCCCC[C@H](O)/C=C/[C@H]1OC(C[C@H](O)[C@@H]1C/C=C\CCCC(O)=O)=O
InChi Code
InChI=1S/C20H32O6/c1-2-3-6-9-15(21)12-13-18-16(17(22)14-20(25)26-18)10-7-4-5-8-11-19(23)24/h4,7,12-13,15-18,21-22H,2-3,5-6,8-11,14H2,1H3,(H,23,24)/b7-4-,13-12+/t15-,16-,17-,18+/m0/s1
InChi Key
KJYIVXDPWBUJBQ-UHHGALCXSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Lipid Resource Center
    Discover Products & Resources for Lipid Research
    • High-purity lipid standards
    • Lipid roles in biology
    • Lipids in health & disease
    • Lipids for pharmaceutical development
    • Protocols, advice, & resources
    EXPLORE NOW
    Product Description

    11-dehydro TXB2 is one of the main plasma metabolites of TXB2 and can be used as a marker for in vivo TXA2 synthesis.1,2,3,4 The mean plasma level in human males is 0.9-4.3 pg/ml and the half life is 45-60 minutes.2,3,4 Urinary concentrations of 11-dehydro TXB2 are approximately 30-70 ng/mmol creatinine.5,6

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Ciabattoni, G., Pugliese, F., Davi, G., et alFractional conversion of thromboxane B2 to urinary 11-dehydrothromboxane B2 in man. Biochim. Biophys. Acta 992(1), 66-70 (1989).

    2. Fitzgerald, G.A., Lawson, J., Blair, I.A., et alAnalysis of urinary metabolites of thromboxane and prostacyclin by negative-ion chemical-ionization gas chromatography/mass spectrometry. Adv. Prostaglandin Thromboxane Leukot. Res. 15, 87-90 (1985).

    3. Takasaki, W., Nakagawa, A., Tanaka, Y., et alEnzyme immunoassay of human plasma 11-dehydrothromboxane B2. Thromb. Res. 63(3), 331-341 (1991).

    4. Catella, F., Healy, D., Lawson, J.A., et al11-dehydro Thromboxane B2: A quantitative index of thromboxane A2 formation in the human circulation. Proc. Natl. Acad. Sci. USA 83(16), 5861-5865 (1986).

    5. Lellouche, F., Fradin, A., FitzGerald, G., et alEnzyme immunoassay measurement of the urinary metabolites of thromboxane A2 and prostacyclin. Prostaglandins 40(3), 297-310 (1990).

    6. Perneby, C., Granström, E., Beck, O., et alOptimization of an enzyme immunoassay for 11-dehydro-thromboxane B2 in urine: Comparison with GC-MS. Thromb. Res. 96(6), 427-436 (1999).

    Product Citations

    Sasaki, A., Fukuda, H., Shiida, N., et alDetermination of ω-6 and ω-3 PUFA metabolites in human urine samples using UPLC/MS/MS. Anal. Bioanal. Chem. 407(6), 1625-1639 (2015).